Monthly Prescribing Reference14h
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.
Pharmabiz4d
Boehringer Ingelheim introduces Semintra 4 mg/ml oral solution in Europe to treat chronic kidney disease and hypertension in cats
Ingelheim, Germany Saturday, February 15, 2025, 12:00 Hrs [IST] ...